3 Stocks Moving The Health Services Industry Upward

TheStreet highlights 3 stocks pushing the health services industry higher today.
By TheStreet Wire ,

Two out of the three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading down 27 points (-0.1%) at 18,429 as of Friday, July 29, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,872 issues advancing vs. 1,043 declining with 148 unchanged.

The Health Services industry currently sits up 0.4% versus the S&P 500, which is up 0.2%. Top gainers within the industry include

Acadia Healthcare

(

ACHC

), up 5.0%,

Mettler-Toledo International

(

MTD

), up 2.9%,

Edwards Lifesciences

(

EW

), up 1.5%,

Abbott Laboratories

(

ABT

), up 0.7% and

Boston Scientific

(

BSX

), up 0.7%. On the negative front, top decliners within the industry include

Cigna

(

CI

), down 4.8%,

Express Scripts

(

ESRX

), down 1.4% and

HCA Holdings

(

HCA

), down 0.7%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

Align Technology

(

ALGN

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Align Technology is up $3.97 (4.7%) to $89.25 on heavy volume. Thus far, 999,591 shares of Align Technology exchanged hands as compared to its average daily volume of 675,000 shares. The stock has ranged in price between $85.15-$89.40 after having opened the day at $85.25 as compared to the previous trading day's close of $85.28.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Align Technology, Inc. Align Technology has a market cap of $6.8 billion and is part of the health care sector. Shares are up 29.5% year-to-date as of the close of trading on Thursday. Currently there are 9 analysts who rate Align Technology a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates

Align Technology

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and expanding profit margins. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Align Technology Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Stryker

(

SYK

) is up $1.44 (1.2%) to $116.40 on average volume. Thus far, 542,718 shares of Stryker exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $114.97-$116.62 after having opened the day at $114.97 as compared to the previous trading day's close of $114.96.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. It operates through three segments: Orthopaedics; MedSurg; and Neurotechnology and Spine. Stryker has a market cap of $43.0 billion and is part of the health care sector. Shares are up 23.7% year-to-date as of the close of trading on Thursday. Currently there are 16 analysts who rate Stryker a buy, 2 analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Stryker

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Stryker Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

UnitedHealth Group

(

UNH

) is up $0.97 (0.7%) to $143.73 on average volume. Thus far, 1.4 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 3.2 million shares. The stock has ranged in price between $141.60-$143.90 after having opened the day at $141.78 as compared to the previous trading day's close of $142.76.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $134.7 billion and is part of the health care sector. Shares are up 21.4% year-to-date as of the close of trading on Thursday. Currently there are 19 analysts who rate UnitedHealth Group a buy, 1 analyst rates it a sell, and 1 rates it a hold.

TheStreet Ratings rates

UnitedHealth Group

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, good cash flow from operations, solid stock price performance and increase in net income. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

UnitedHealth Group Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

Loading ...